The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture

Clinical Endocrinology

Volumn 77, Issue 5, 2012, Pages 672-678

  Pepe, Jessica ^a   Isidori, Andrea M ^b   Falciano, Mario ^c   Iaiani, Giancarlo ^c   Salotti, Alessandra ^c   Diacinti, Daniele ^a   Del Fiacco, Romano ^a   Sbardella, Emilia ^b   Cipriani, Cristiana ^a   Piemonte, Sara ^a   Romagnoli, Elisabetta ^a   Lenzi, Andrea ^b   Minisola, Salvatore ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ADULT; AGED; AGING MALE SYMPTOM SCALE; ALGORITHM; ARTICLE; BONE DENSITY; BONE FRAGILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FRACTURE; FRAX ALGORITHM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP FRACTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGONADISM; MALE; MINERAL METABOLISM; OBSERVATIONAL STUDY; OSTEOPOROSIS; PRIORITY JOURNAL; RATING SCALE; SENSITIVITY AND SPECIFICITY; SPINE FRACTURE;

ADULT; AGED; ALGORITHMS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BONE DENSITY; CROSS-SECTIONAL STUDIES; FRACTURES, BONE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; QUESTIONNAIRES;

EID: 84867271388     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04452.x     Document Type: Article

References (32)

1. Brown, T.T., &, Qaqish, R.B., (2006) Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS, 17, 2165-2174. (Pubitemid 44684707)
2. Triant, V.A., Brown, T.T., Lee, H., et al,. (2008) Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. Journal of Clinical Endocrinology & Metabolism, 93, 3499-3504.
3. Collin, F., Duval, X., Le Moing, V., et al,. (2009) Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV 1-infected adults. AIDS, 23, 1021-1024.
4. Mansky, K.C., (2010) Aging, human immunodeficiency virus, and bone health. Clinical Interventions in Aging, 5, 285-292.
5. Fink, H.A., Ewing, S.K., Ensrud, K.E., et al,. (2006) Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. Journal of Clinical Endocrinology & Metabolism, 91, 3908-3915. (Pubitemid 44536863)
6. Moreno-Pérez, O., Escoín, C., Serna-Candel, C., et al,. (2010) The determination of total testosterone and free testosterone (RIA) are not applicable to the evaluation of gonadal function in HIV-infected males. Journal of Sexual Medicine, 7, 2873-2883.
7. Cotter, A.G., &, Powderly, W.G., (2011) Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity. Best Practice & Research Clinical Endocrinology & Metabolism, 25, 501-515.
8. Kanis, J.A., Johnell, O., Oden, A., et al,. (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporosis International, 19, 385-397.
9. Lundgren, J.D., Battegay, M., Behrens, G., et al,. (2008) European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV. HIV Medicine, 9, 72-81. (Pubitemid 351232645)
10. Silverman, S.L., &, Calderon, A.D., (2010) The utility and limitations of FRAX: a US perspective. Current Osteoporosis Report, 8, 192-197.
11. Daig, I., Heinemann, L. A., Kim, S., et al,. (2003) The Aging Males' Symptoms (AMS) scale: review of its methodological characteristics. Health and Quality of Life Outcomes 15, 1-77.
12. Morley, J.E., Perry II H.M., Kevorkian, R.T., et al,. (2006) Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas, 3, 424-429.
13. Pepe, J., Romagnoli, E., Nofroni, I., et al,. (2005) Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects. Osteoporosis International, 16, 805-812. (Pubitemid 40933597)
14. Cockcroft, D.W., &, Gault, M.H., (1976) Prediction of creatinine clearance from serum creatinine. Nephron, 16, 31-41.
15. Iuliano, R., Forastieri, G., Brizzi, M., et al,. (1995) HIV-plasma viral load detection by branched DNA signal amplification. New Microbiologica, 18, 299-301.
16. Manasa, J., Musabaike, H., Masimirembwa, C., et al,. (2007) Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe. Clinical and Vaccine Immunology, 14, 293-298. (Pubitemid 46570287)
17. Fabbri, A., Jannini, E.A., Ulisse, S., et al,. (1988) Serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility. Journal of Clinical Endocrinology & Metabolism, 67, 867-875.
18. Vermeulen, A., Verdonck, L., &, Kaufman, J.M., (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology & Metabolism, 84, 3666-3667.
19. Genant, H.K., Wu, C.Y., van Kuijk, C., et al,. (1993) Vertebral fracture assessment using a semiquantitative technique. Journal of Bone and Mineral Research, 9, 1137-1148. (Pubitemid 23261108)
20. Gonnelli, S., Rossi, S., Montomoli, M., et al,. (2009) Accuracy of different reduced versions of a validated food-frequency questionnaire in Italian men and women. Calcified Tissue International, 85, 221-227.
21. Ross, A.C., Manson, J.E., Abrams, S.A., et al,. (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. Journal of Clinical Endocrinology & Metabolism, 96, 53-58.
22. Kanis, J.A., McCloskey, E.V., Johansson, H., et al,. (2009) Case finding for the management of osteoporosis with FRAX ®-assessment and intervention thresholds for the UK.; National Osteoporosis Guideline Group. Osteoporosis International, 20, 499-502.
23. Vescini, F., Cozzi-Lepri, A., Borderi, M., et al,. (2011) Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. Journal of Acquired Immune Deficiency Syndrome, 58, 163-172.
24. Overton, E.T., &, Yin, M.T., (2011) The rapidly evolving research on Vitamin D among HIV-infected populations. Current Infectious Disease Reports, 13, 83-93.
25. Heinemann, L.A., Saad, F., Heinemann, K., et al,. (2004) Can results of the Aging Males' Symptoms (AMS) scale predict those of screening scales for androgen deficiency? Aging Male, 7, 211-218. (Pubitemid 39315125)
26. Carruthers, M., (2008) The paradox dividing testosterone deficiency symptoms and androgen assays: a closer look at the cellular and molecular mechanisms of androgen action. Journal of Sexual Medicine, 5, 998-1012. (Pubitemid 351472215)
27. Morales, A., Spevack, M., Emerson, L., et al,. (2007) Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry. Aging Male, 10, 57-65. (Pubitemid 46904746)
28. Trinick, T.R, Feneley, M.R., Welford, H., et al,. (2011) International web survey shows high prevalence of symptomatic testosterone deficiency in men. Aging Male, 14, 10-15.
29. Gazzola, L., Comi, L., Savoldi, A., et al,. (2010) Use of the FRAX equation as first-line screening of bone metabolism alteration in the HIV-infected population. Journal of Infectious Disease, 202, 330-331.
30. Calmy, A., Fux, C.A., Norris, R., et al,. (2009) Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study. Journal of Infectious Disease, 200, 1746-1754.
31. Blank, R.D., & FRAX(®) Position Development Conference Members. (2011) Official positions for FRAX(®) clinical regarding prior fractures from joint official positions development conference of the international society for clinical densitometry and international osteoporosis foundation on FRAX(®). Journal of Clinical Densitometry, 14, 205-211.
32. McComsey, G.A., Kendall, M.A., Tebas, P., et al,. (2007) Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. AIDS, 21, 2473-2482. (Pubitemid 350145179)